China Biologic Products Inc news

   Watch this stock
Showing stories 1 - 10 of about 64   

Articles published

CBPO 40.15 +1.63 (4.24%)
price chart
China Biologic Announces Favorable Resolution to Title Dispute Involving ...
BEIJING, April 2, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has learned that ...
Related articles »  
Get Quote Search Site
... obligation to you. If you own common stock in China Biologic Products, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq.
Related articles »  
Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics ...
China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year 2013.
Healthcare Gainers: Fate Therapeutics (NASDAQ:FATE), China Biologic ...
China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , announced its financial results for the fourth quarter and fiscal year 2013.
Related articles »  
Thermo Fisher Scientific CEO Discusses Q1 2014 Results - Earnings Call ...
To provide you with a little more color from a product perspective, we're pleased with our ongoing strength in chromatography, and we saw a nice pickup during the quarter in our portable analyzer business.
Related articles »  
Biogen Idec First Quarter 2014 Revenues Reach $2.1 Billion Driven by ...
BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today reported first quarter 2014 results, including revenue of $2.1 billion, a 51% increase compared to the first quarter of 2013.
BIOGEN IDEC FIRST QUARTER 2014 REVENUES REACH $2.1 BILLION ...  FiercePharma
Related articles »  
Give Your Grocery Bill a Kick in the Teeth with This Tech Investing Play
This is a profit play you can feel good about holding: The small-cap firm is a global leader in food and agriculture technology, and its offerings help make sure the food sector's crops, animals, and products are clean, safe, and healthy. In my book ...
Strong market breadth
Lupin edged higher after the company announced that it has entered into a strategic joint venture agreement with Toyama based Japanese pharmaceuticals company, Yoshindo Inc. (Yoshindo) to create a new entity, YL Biologics (YLB). Among bank stocks ...
Related articles »  
One-Armed Biker Leads as Paulistas Take to Cycling
The once-ubiquitous two-wheeler is returning to China's streets after its fleet shrank by 35 percent in the decade ending in 2005.
Related articles »  
Nifty ends at record closing high on expiry day; banks lead
European shares edged down after three days of gains as data showing China's economy was still stuttering offset some broadly reassuring European purchasing manager index (PMI) numbers.
Related articles »